Sotatercept Endorsed for PAH by ICER

Drug's novel mechanism of action raises hopes of disease-modifying activity, but long-term cost-effectiveness rests on improvement in functional status.
Medscape Medical News

source https://www.medscape.com/viewarticle/sotatercept-endorsed-pah-icer-2023a1000uef?src=rss